IMR Press / FBL / Volume 16 / Issue 4 / DOI: 10.2741/3803

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

The FERM family proteins in cancer invasion and metastasis
Show Less
1 Department of Biochemistry and Molecular Biology, School of Basic Medicine, Capital Medical University, Beijing, PR China
2 Metastasis & Angiogenesis Research Group, Department of Surgery, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK

Academic Editors: Wen G Jiang, Richard Ablin

Front. Biosci. (Landmark Ed) 2011, 16(4), 1536–1550;
Published: 1 January 2011
(This article belongs to the Special Issue Bone metastasis, the molecular, cellular and clinical prospects)

Metastasis is the major cause of death in patients with cancer. Metastatic cancer cells undergo dramatic molecular and cellular changes by remodeling their cell-cell and cell-matrix adhesion and their actin cytoskeleton, molecular processes that involve the activity of various signaling networks. The FERM family proteins can link transmembrane proteins to the cytoskeleton or link kinase and/or phosphatase enzymatic activity to the plasma membrane. They thus are involved not only in cell-extracellular matrix interactions and cell-cell communication but also in apoptosis, carcinogenesis and metastasis. This review will summarize the role and mechanism of FERM proteins, with particular reference to the ERM and Ehm2 proteins in cancer metastasis.

Back to top